← 返回

CD4(+) T 细胞在肿瘤和慢性病毒免疫反应中的作用

英文原题:The role of CD4(+) T cells in tumor and chronic viral immune responses.

查看英文原题

The role of CD4(+) T cells in tumor and chronic viral immune responses.

PubMed 2023/10/10(内容时间) MedComm (2020) Q1 · IF 14.1(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

免疫疗法主要旨在促进CD8+ T细胞反应而非CD4+ T细胞反应,因为细胞毒性T淋巴细胞(CTLs)能够直接杀伤靶细胞。近年来,CD4+ T细胞因其在肿瘤和慢性病毒感染中的多样作用而受到更多关注。在抗肿瘤和抗慢性病毒反应中,CD4+ T细胞通过树突状细胞传递辅助信号,间接调节CD8+ T细胞反应,与B细胞或巨噬细胞相互作用以间接调节体液免疫或巨噬细胞极化,并抑制肿瘤血管形成。此外,CD4+ T细胞还可以对靶细胞表现出直接细胞毒性。然而,调节性T细胞表现出免疫抑制,且CD4+ T细胞发生耗竭,从而促进肿瘤进展和慢性病毒持续存在。最后,我们还概述了基于CD4+ T细胞的免疫疗法,包括过继细胞转移、疫苗和免疫检查点阻断。总体而言,本综述总结了CD4+ T细胞在抗肿瘤或促肿瘤及慢性病毒反应中的多样作用,并重点介绍了基于CD4+ T细胞的免疫疗法,从而更好地理解其在肿瘤和慢性病毒感染中的作用。

展开英文摘要原文

Immunotherapies are mainly aimed to promote a CD8 + T cell response rather than a CD4 + T cell response as cytotoxic T lymphocytes (CTLs) can directly kill target cells. Recently, CD4 + T cells have received more attention due to their diverse roles in tumors and chronic viral infections.

In antitumor and antichronic viral responses, CD4 + T cells relay help signals through dendritic cells to indirectly regulate CD8 + T cell response, interact with B cells or macrophages to indirectly modulate humoral immunity or macrophage polarization, and inhibit tumor blood vessel formation.

Additionally, CD4 + T cells can also exhibit direct cytotoxicity toward target cells.

However, regulatory T cells exhibit immunosuppression and CD4 + T cells become exhausted, which promote tumor progression and chronic viral persistence.

Finally, we also outline immunotherapies based on CD4 + T cells, including adoptive cell transfer, vaccines, and immune checkpoint blockade.

Overall, this review summarizes diverse roles of CD4 + T cells in the antitumor or protumor and chronic viral responses, and also highlights the immunotherapies based on CD4 + T cells, giving a better understanding of their roles in tumors and chronic viral infections.

论文信息

作者
Xie L、Fang J、Yu J、Zhang W、He Z、Ye L、Wang H
单位
Institute of Hepatopancreatobiliary Surgery Chongqing General Hospital Chongqing China.China
文献类型
综述
期刊
MedComm2023 Oct
原文标识
PubMed 37829505 · DOI 10.1002/mco2.390